The healthcare market in the Middle East is expanding rapidly, with the United Arab Emirates (UAE) emerging as a core market due to its high demand and growth potential. Al Khayyat Investments (AKI), the UAE’s third-largest healthcare distributor, is set to visit Taiwan for the December Medical Technology Exhibition, aiming to explore collaboration opportunities and introduce Taiwan's innovative healthcare technologies to the Middle Eastern market.
According to Taiwan's Ministry of Economic Affairs, the UAE ranks as the fourth-largest medical equipment market in the MENA (Middle East and North Africa) region and leads in per capita spending. Over the next five years, this market is expected to grow at an average annual rate of 8.4%, with a projected total market size surpassing USD 200 million. However, the UAE's reliance on imports for medical equipment—due to local production mainly focusing on disposable medical supplies and basic components—presents international suppliers with ample business opportunities.
Founded in 1982 with an initial focus on pharmaceuticals, AKI has grown into a diversified enterprise valued at billions of dollars. Representing over 100 international brands, AKI’s product portfolio spans medical equipment, pharmaceuticals, and healthcare products, with a reach across public and private hospitals, clinics, and pharmacies throughout the Middle East, covering 98% of the market. As a leading brand in the region's healthcare sector, AKI’s strong market presence and extensive product lineup make it a key partner for medical institutions, annually treating over 3.2 million patients and supporting the registration of more than 4,000 pharmaceutical products.
AKI also operates BinSina Pharmacy, the UAE’s first pharmacy chain, with over 150 branches, including flagship locations in Dubai Healthcare City—a hub for prominent medical institutions and teaching centers—and branches in Dubai Mall and Abu Dhabi’s Galleria Mall.
In its upcoming visit to Taiwan, AKI seeks to leverage Taiwan’s technological advances in digital health, cell storage, and oncology testing. The company plans to identify promising suppliers to expand its product lineup, addressing the increasing healthcare demands of the UAE and broader Middle Eastern markets. For Taiwanese companies, partnering with AKI offers a strategic pathway into the Middle East. AKI’s robust market resources and distribution network can help rapidly integrate Taiwan’s cutting-edge innovations into the local healthcare landscape, creating new business opportunities and fostering mutual growth in medical technology between the two regions.
Resource (mandarin): 阿聯醫療需求增長 第三大通路商Al Khayyat Investments來台尋求合作契機
